These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26709083)

  • 1. NF-κB and androgen receptor variant expression correlate with human BPH progression.
    Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW
    Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.
    Austin DC; Strand DW; Love HL; Franco OE; Grabowska MM; Miller NL; Hameed O; Clark PE; Matusik RJ; Jin RJ; Hayward SW
    Prostate; 2016 Aug; 76(11):1004-18. PubMed ID: 27197599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy.
    Liu VWS; Yau WL; Tam CW; Yao KM; Shiu SYW
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.
    Deng C; Chen J; Guo S; Wang Y; Zhou Q; Li Z; Yang X; Yu X; Zhang Z; Zhou F; Han H; Yao K
    World J Urol; 2017 Aug; 35(8):1213-1221. PubMed ID: 28105499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants.
    Morel KL; Hamid AA; Clohessy JG; Pandell N; Ellis L; Sweeney CJ
    Mol Cancer Res; 2021 Jul; 19(7):1137-1145. PubMed ID: 33863813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
    Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
    Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
    Wen S; Chang HC; Tian J; Shang Z; Niu Y; Chang C
    Am J Pathol; 2015 Feb; 185(2):293-301. PubMed ID: 25432062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer.
    Hillebrand AC; Pizzolato LS; Neto BS; Branchini G; Brum IS
    PLoS One; 2018; 13(7):e0200613. PubMed ID: 30028845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway.
    Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY
    Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cells.
    Sasaki T; Yoshikawa Y; Kageyama T; Sugino Y; Kato M; Masui S; Nishikawa K; Inoue T
    Prostate; 2023 Mar; 83(4):364-375. PubMed ID: 36479717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
    Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
    Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of potential regulatory signaling molecules correlate with androgen receptor splice variants AR-V7 and AR-V567es in prostate cancer metastasis.
    Kiliccioglu I; Bilen CY; Sozen S; Konac E
    Gene; 2021 Mar; 772():145377. PubMed ID: 33359129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
    Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
    Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
    Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
    J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
    Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
    Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects.
    Duprat F; Robles C; Castillo MP; Rivas Y; Mondaca M; Jara N; Roa F; Bertinat R; Toledo J; Paz C; González-Chavarría I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer.
    Yu J; Sun L; Hao T; Zhang B; Chen X; Li H; Zhang Z; Zhu S; Quan C; Niu Y; Shang Z
    Ann Transl Med; 2019 Dec; 7(23):729. PubMed ID: 32042745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor variant-7 regulation by tenascin-c induced src activation.
    Thomas R; Jerome JM; Dang TD; Souto EP; Mallam JN; Rowley DR
    Cell Commun Signal; 2022 Aug; 20(1):119. PubMed ID: 35948987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
    Lai KP; Huang CK; Fang LY; Izumi K; Lo CW; Wood R; Kindblom J; Yeh S; Chang C
    Mol Endocrinol; 2013 Oct; 27(10):1617-31. PubMed ID: 23893956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.